Received: 18 August 2021
Accepted: 11 March 2022
First Online: 1 April 2022
: The study was approved by the Malaysia Ministry of Health Medical Research Ethics Committee (reference number NMRR-19-3860-52267) and the Research Ethics Committee (REC/04/2020), Universiti Teknologi MARA (UiTM). All methods in this study were performed according to the ICH Good Clinical Practice Guidelines, Malaysia Good Clinical Practice Guidelines, and the Declaration of Helsinki.This was a cross-sectional study that involved secondary data analysis from the National MyTB database version 2.1 in 2013 to 2017 from the Disease Control Division, Ministry of Health. Thus, no consent from respondent was required. A formal request for data utilization was made from the Disease Control Division, Ministry of Health Malaysia prior to study initiation. Registered TB cases were kept anonymous and given a unique identification numbering. This research involves no more than minimal risk to subject, thus the requirement to obtained informed consent to participate has been waived by the Research Ethics Committee (REC/04/2020), Universiti Teknologi MARA (UiTM) and Malaysia Ministry of Health Medical Research Ethics Committee (reference number NMRR-19-3860-52267).
: Not applicable.
: All authors declare that they have no competing interests and no potential conflict of interest regarding the publication of this study article.